XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities    
Net (loss) income $ (34,835) $ 3,952
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 1,158 2,812
Provision for unrecoverable advances 13,785 3,538
Changes in fair value of derivative assets 5,572 (17,146)
Changes in fair value of warrant liabilities 4,065 2,186
Stock-based compensation 3,190 1,694
Non-cash interest (63) (68)
Non-cash lease expense (23) (2)
Changes in fair value of marketable securities 76 (2)
Changes in operating assets and liabilities:    
Member advances (26,585) 4,987
Prepaid income taxes 22 788
Prepaid expenses and other current assets (4,847) (497)
Accounts payable 2,489 238
Accrued expenses (1,039) 1,609
Income taxes payable   0
Legal settlement accrual (125)  
Other current liabilities (321) (1,450)
Other non-current liabilities 2 (23)
Interest payable, convertible notes   3
Net cash (used in) provided by operating activities (37,479) 2,619
Investing activities    
Payments for internally developed software costs (2,258) (3,298)
Purchase of property and equipment (228) (5)
Purchase of marketable securities (302,115) (2)
Sale of marketable securities 32,000 3,915
Net cash (used in) provided by investing activities (272,601) 610
Financing activities    
Repayment on line of credit   (3,910)
Proceeds from PIPE offering 195,000  
Proceeds from escrow account, net of redemptions 29,688  
Payment of issuance costs (22,944) (120)
Proceeds from issuance of common stock for stock option exercises 1,563 599
Repurchase of common stock (1,583)  
Proceeds from borrowings on convertible debt 100,000  
Proceeds from borrowings on debt and credit facilities   19,000
Net cash provided by financing activities 301,724 15,569
Net (decrease) increase in cash and cash equivalents and restricted cash (8,356) 18,798
Cash and cash equivalents and restricted cash, beginning of the period 32,372 5,069
Cash and cash equivalents and restricted cash, end of the period 24,016 23,867
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible preferred stock to Class A common stock in connection with the reverse recapitalization 72,173  
Recapitalization transaction costs liability incurred 7,500  
Conversion of convertible notes and accrued interest to Class A common stock in connection with the reverse recapitalization 720  
Conversion of B-1 Warrants to Class A common stock in connection with the reverse recapitalization 3,365  
Discharge of PIPE promissory note in connection with the reverse recapitalization 15,000  
Supplemental disclosure of cash (received) paid for:    
Income taxes (2) (776)
Interest 1,392 269
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheet with the same as shown in the condensed consolidated statement of cash flows.    
Cash and cash equivalents 23,569 23,438
Restricted cash 447 429
Total cash, cash equivalents, and restricted cash, end of period $ 24,016 $ 23,867